☆ 4.6 Article

PRMT1 Regulates EGFR and Wnt Signaling Pathways and Is a Promising Target for Combinatorial Treatment of Breast Cancer

CANCERS (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Chemistry, Medicinal

Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer

Kyu Sic You et al.

Summary: Triple-negative breast cancer (TNBC) is a subset of breast cancer with aggressive characteristics and limited therapeutic options, posing a challenge due to the lack of appropriate therapeutic targets. Despite the association of high EGFR expression with poor prognosis in TNBC patients, targeted anti-EGFR therapies have shown limited efficacy. Combination strategies using clinically approved EGFR inhibitors offer a promising approach to overcoming TNBC's intrinsic resistance to EGFR inhibitors.

PHARMACEUTICALS (2021)

添加到收藏夹

Article Biology

Arginine Methyltransferase PRMT1 Regulates p53 Activity in Breast Cancer

Li-Ming Liu et al.

Summary: PRMT1 serves as a key regulator of p53 function in breast cancer cells, inhibiting the transcriptional activity of p53 and affecting cell growth and senescence. Inhibition of PRMT1 with specific inhibitors can significantly weaken p53 signals and impede cell growth in breast cancer cells, highlighting the important role of PRMT1 in breast tumorigenesis.

LIFE-BASEL (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

PRMT1 enhances oncogenic arginine methylation of NONO in colorectal cancer

Xin-Ke Yin et al.

Summary: Arginine methylation, catalyzed by PRMTs, plays a crucial role in CRC. Overexpression of NONO in CRC tissue is associated with poor prognosis. Methylation of NONO by PRMT1 at R251 promotes CRC growth and metastasis, indicating PRMT1 inhibition as a potential therapeutic strategy for CRC treatment.

ONCOGENE (2021)

添加到收藏夹

Review Cell Biology

CARM1/PRMT4: Making Its Mark beyond Its Function as a Transcriptional Coactivator

Samyuktha Suresh et al.

Summary: CARM1, originally identified as a coregulator of transcription, has been found to have novel roles in autophagy, metabolism, paraspeckles, and early development apart from its well-established involvement in transcriptional coactivation. It is also gaining attention as a promising therapeutic target and drug response biomarker in certain types of cancer.

TRENDS IN CELL BIOLOGY (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Cellular pathways influenced by protein arginine methylation: Implications for cancer

Jian Xu et al.

Summary: Arginine methylation is a crucial post-translational modification that influences protein function and has significant implications for cancer therapy. Protein arginine methyltransferases (PRMTs) have been implicated in various cellular processes and are being explored as potential drug targets for cancer treatment, with some inhibitors already in clinical trials.

MOLECULAR CELL (2021)

添加到收藏夹

Article Oncology

Synergistic effects of type I PRMT and PARP inhibitors against non-small cell lung cancer cells

Claudia Dominici et al.

Summary: The study finds that PARP inhibitors have a strong synergistic interaction with Type I PRMT inhibitors in NSCLC cells, significantly reducing cell viability. Re-introduction of MTAP decreases the sensitivity of the combination therapy in A549 cells, while the combination therapy leads to increased DNA damage and decreased cell viability. The combination therapy is also effective in PARPi resistant ovarian cancer cells, indicating the potential clinical impact of type I PRMT inhibitors in mitigating PARPi resistance.

CLINICAL EPIGENETICS (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

PRMT1 promotes the tumor suppressor function of p14ARF and is indicative for pancreatic cancer prognosis

Antje Repenning et al.

Summary: The study reveals that PRMT1-mediated arginine methylation is crucial for triggering stress-induced tumor-suppressive function of p14(ARF). The interaction between PRMT1 and p14(ARF) leads to the release of p14(ARF) from nucleoli, promoting p53-independent apoptosis in response to genotoxic stress. This cooperation between PRMT1 and p14(ARF) has implications for cancer prognosis and chemotherapy response in pancreatic ductal adenocarcinoma.

EMBO JOURNAL (2021)

添加到收藏夹

Review Medicine, General & Internal

Breast cancer

Sibylle Loibl et al.

Summary: Breast cancer diagnosis and treatment have become increasingly complex, incorporating various biomarkers and neoadjuvant therapies, with de-escalation schemes for radiotherapy now becoming standard practice.

LANCET (2021)

添加到收藏夹

Article Health Care Sciences & Services

PRMT1 Confers Resistance to Olaparib via Modulating MYC Signaling in Triple-Negative Breast Cancer

Wen-Jing Hsu et al.

Summary: Elevated expression of PRMT1 was found to be associated with therapeutic sensitivity to the PARP inhibitor olaparib in TNBC cells, particularly those with higher PRMT1 and MYC signature. PRMT1 was shown to modulate DNA repair by regulating c-Myc signaling, highlighting the PRMT1/c-Myc network as a potential therapeutic target in patients with TNBC.

JOURNAL OF PERSONALIZED MEDICINE (2021)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Protein arginine methylation: from enigmatic functions to therapeutic targeting

Qin Wu et al.

Summary: PRMTs are emerging as attractive therapeutic targets due to their regulation of essential biological processes such as transcription, splicing, RNA biology, DNA damage response, and cell metabolism, which are often disrupted in diseases. Understanding how these enzymes support cancer cell growth in specific metabolic contexts or in the presence of certain mutations has provided the rationale for targeting them in oncology, with ongoing inhibitor development and in-depth mechanistic investigations guiding future clinical development.

NATURE REVIEWS DRUG DISCOVERY (2021)

添加到收藏夹

Review Biology

Structure, Activity, and Function of PRMT1

Charlene Thiebaut et al.

Summary: PRMT1, the major protein arginine methyltransferase in mammals, plays essential roles in various biological processes such as transcriptional regulation, signal transduction, and DNA repair. It catalyzes monomethylation and asymmetric dimethylation of arginine side chains in proteins, with a wide range of substrates identified including histone and non-histone proteins. The enzyme is also involved in embryonic development, DNA damage repair, and the progression of various cancers.

LIFE-BASEL (2021)

添加到收藏夹

Review Oncology

Triple-negative breast cancer: A run-through of features, classification and current therapies

Meghana Manjunath et al.

Summary: TNBC is the most aggressive subtype of breast cancer, with challenging treatment due to its heterogeneity. Recent research and new therapies have brought hope for the treatment of TNBC.

ONCOLOGY LETTERS (2021)

添加到收藏夹

Article Genetics & Heredity

PRMT1-mediated H4R3me2a recruits SMARCA4 to promote colorectal cancer progression by enhancing EGFR signaling

Bing Yao et al.

Summary: PRMT1-mediated H4R3me2a recruits SMARCA4, which promotes colorectal cancer progression by enhancing EGFR signaling.

GENOME MEDICINE (2021)

添加到收藏夹

Review Oncology

Triple-negative breast cancer: understanding Wnt signaling in drug resistance

Parnaz Merikhian et al.

Summary: Triple-negative breast cancer presents challenges in treatment strategies due to its complexity and heterogeneity, with research showing the pivotal role of Wnt/beta-catenin signaling in resistance development.

CANCER CELL INTERNATIONAL (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Pharmacologic modulation of RNA splicing enhances anti-tumor immunity

Sydney X. Lu et al.

Summary: The study demonstrates that modulation of splicing through specific drug classes generates genuine neoantigens and enhances anti-tumor immunity, augmenting checkpoint immunotherapy.

CELL (2021)

添加到收藏夹

Article Multidisciplinary Sciences

PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma

Virginia Giuliani et al.

Summary: PRMT1 plays a critical role in the maintenance of pancreatic ductal adenocarcinoma (PDAC) growth by regulating RNA metabolism and influencing multiple cellular processes. Inhibition of PRMT1 leads to downregulation of pathways involved in DNA damage response, promoting genomic instability and inhibiting tumor growth.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Article Medicine, Research & Experimental

PRMT1 is a novel molecular therapeutic target for clear cell renal cell carcinoma

Jianfeng Wang et al.

Summary: The study revealed that PRMT1 overexpression is associated with poor clinicopathological features and outcomes in clear cell renal cell carcinoma. PRMT1 promotes ccRCC cell growth by inducing G1 cell cycle arrest. LCN2 functions as a crucial downstream effector of PRMT1 in regulating ccRCC growth.

THERANOSTICS (2021)

添加到收藏夹

Article Cell Biology

PRMT1 Is Recruited via DNA-PK to Chromatin Where It Sustains the Senescence-Associated Secretory Phenotype in Response to Cisplatin

Daniele Musiani et al.

CELL REPORTS (2020)

添加到收藏夹

Article Biochemical Research Methods

Proteome-wide identification of arginine methylation in colorectal cancer tissues from patients

Yongchul Lim et al.

PROTEOME SCIENCE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

PRMT1 Is Critical for the Transcriptional Activity and the Stability of the Progesterone Receptor

Lucie Malbeteau et al.

ISCIENCE (2020)

添加到收藏夹

Article Oncology

PRMT2 accelerates tumorigenesis of hepatocellular carcinoma by activating Bcl2 via histone H3R8 methylation

Guohui Hu et al.

EXPERIMENTAL CELL RESEARCH (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

Combining protein arginine methyltransferase inhibitor and anti-programmed death-ligand-1 inhibits pancreatic cancer progression

Nan-Nan Zheng et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

PRMT1 inhibition induces differentiation of colon cancer cells

Alexander Plotnikov et al.

SCIENTIFIC REPORTS (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

PRMT1 loss sensitizes cells to PRMT5 inhibition

Guozhen Gao et al.

NUCLEIC ACIDS RESEARCH (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

The arginine methyltransferase PRMT1 regulates IGF-1 signaling in breast cancer

Ali Choucair et al.

ONCOGENE (2019)

添加到收藏夹

Review Pharmacology & Pharmacy

Modulating Wnt signaling at the root: Porcupine and Wnt acylation

Viviana I. Torres et al.

PHARMACOLOGY & THERAPEUTICS (2019)

添加到收藏夹

Article Oncology

Methylation of C/EBPa by PRMT1 Inhibits Its Tumor-Suppressive Function in Breast Cancer

Li-Ming Liu et al.

CANCER RESEARCH (2019)

添加到收藏夹

Article Oncology

Protein arginine methyltransferase 5: A novel therapeutic target for triple-negative breast cancers

Mathilde Vinet et al.

CANCER MEDICINE (2019)

添加到收藏夹

Article Hematology

PRMT1-mediated FLT3 arginine methylation promotes maintenance of FLT3-ITD+ acute myeloid leukemia

Xin He et al.

BLOOD (2019)

添加到收藏夹

Article Oncology

Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss

Andrew Fedoriw et al.

CANCER CELL (2019)

添加到收藏夹

Review Cell Biology

The regulation, functions and clinical relevance of arginine methylation

Ernesto Guccione et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)

添加到收藏夹

Review Biochemistry & Molecular Biology

PRMTs and Arginine Methylation: Cancer's Best-Kept Secret?

James Jarrold et al.

TRENDS IN MOLECULAR MEDICINE (2019)

添加到收藏夹

Article Hematology

Targeting PRMT1-mediated FLT3 methylation disrupts maintenance of MLL-rearranged acute lymphoblastic leukemia

Yinghui Zhu et al.

BLOOD (2019)

添加到收藏夹

Article Oncology

Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation

Jia Yi Fong et al.

CANCER CELL (2019)

添加到收藏夹

Article Pathology

PRMT1 expression in renal cell tumors- application in differential diagnosis and prognostic relevance

Jelena Filipovic et al.

DIAGNOSTIC PATHOLOGY (2019)

添加到收藏夹

Article Oncology

LKB1 regulates PRMT5 activity in breast cancer

Hanine Lattouf et al.

INTERNATIONAL JOURNAL OF CANCER (2019)

添加到收藏夹

Article Oncology

The role of PRMT1 in EGFR methylation and signaling in MDA-MB-468 triple-negative breast cancer cells

Katsuya Nakai et al.

BREAST CANCER (2018)

添加到收藏夹

Article Cell Biology

PRMT1 Promoted HCC Growth and Metastasis In Vitro and In Vivo via Activating the STAT3 Signalling Pathway

Xiu-Ping Zhang et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)

添加到收藏夹

Article

LRP5 regulates the expression of STK40, a new potential target in triple-negative breast cancers

Sylvie Maubant et al.

Oncotarget (2018)

添加到收藏夹

Article Oncology

PRMT1 expression is elevated in head and neck cancer and inhibition of protein arginine methylation by adenosine dialdehyde or PRMT1 knockdown downregulates proliferation and migration of oral cancer cells

Chun-Yi Chuang et al.

ONCOLOGY REPORTS (2017)

添加到收藏夹

Review Oncology

Wnt signaling in triple-negative breast cancer

SO-G Pohl et al.

ONCOGENESIS (2017)

添加到收藏夹

Article Cell Biology

CSNK1a1 Regulates PRMT1 to Maintain the Progenitor State in Self-Renewing Somatic Tissue

Xiaomin Bao et al.

DEVELOPMENTAL CELL (2017)

添加到收藏夹

Article Biochemistry & Molecular Biology

A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases

Mohammad S. Eram et al.

ACS CHEMICAL BIOLOGY (2016)

添加到收藏夹

Article Biochemical Research Methods

Combenefit: an interactive platform for the analysis and visualization of drug combinations

Giovanni Y. Di Veroli et al.

BIOINFORMATICS (2016)

添加到收藏夹

Review Oncology

Protein arginine methylation/demethylation and cancer

Coralie Poulard et al.

ONCOTARGET (2016)

添加到收藏夹

Article Multidisciplinary Sciences

The dual function of PRMT1 in modulating epithelial-mesenchymal transition and cellular senescence in breast cancer cells through regulation of ZEB1

Yanyan Gao et al.

SCIENTIFIC REPORTS (2016)

添加到收藏夹

Article Medicine, Research & Experimental

PRMT1-mediated methylation of the EGF receptor regulates signaling and cetuximab response

Hsin-Wei Liao et al.

JOURNAL OF CLINICAL INVESTIGATION (2015)

添加到收藏夹

Review Genetics & Heredity

Arginine methyltransferases as novel therapeutic targets for breast cancer

Alan Morettin et al.

MUTAGENESIS (2015)

添加到收藏夹

Review Pharmacology & Pharmacy

What is synergy? The Saariselka agreement revisited

Jing Tang et al.

FRONTIERS IN PHARMACOLOGY (2015)

添加到收藏夹

Article Multidisciplinary Sciences

Transcriptome Analysis of Wnt3a-Treated Triple-Negative Breast Cancer Cells

Sylvie Maubant et al.

PLOS ONE (2015)

添加到收藏夹

Article Cell Biology

5-Hydroxymethylcytosine Plays a Critical Role in Glioblastomagenesis by Recruiting the CHTOP-Methylosome Complex

Hiroki Takai et al.

CELL REPORTS (2014)

添加到收藏夹

Article Oncology

Polo-like Kinase 1: A Potential Therapeutic Option in Combination with Conventional Chemotherapy for the Management of Patients with Triple-Negative Breast Cancer

Virginie Maire et al.

CANCER RESEARCH (2013)

添加到收藏夹

Article Multidisciplinary Sciences

TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast Cancer

Virginie Maire et al.

PLOS ONE (2013)

添加到收藏夹

Review Oncology

Protein arginine methyltransferases and cancer

Yanzhong Yang et al.

NATURE REVIEWS CANCER (2013)

添加到收藏夹

Article Cell Biology

Alternatively spliced protein arginine methyltransferase 1 isoform PRMT1v2 promotes the survival and invasiveness of breast cancer cells

R. Mitchell Baldwin et al.

CELL CYCLE (2012)

添加到收藏夹

Article Cell Biology

Wnt3a-stimulated LRP6 phosphorylation is dependent upon arginine methylation of G3BP2

Rama Kamesh Bikkavilli et al.

JOURNAL OF CELL SCIENCE (2012)

添加到收藏夹

Article Multidisciplinary Sciences

Dishevelled3 is a novel arginine methyl transferase substrate

Rama Kamesh Bikkavilli et al.

SCIENTIFIC REPORTS (2012)

添加到收藏夹

Article Oncology

Dysregulation of PRMT1 and PRMT6, Type I arginine methyltransferases, is involved in various types of human cancers

Masanori Yoshimatsu et al.

INTERNATIONAL JOURNAL OF CANCER (2011)

添加到收藏夹

Article Cell Biology

Arginine methylation of G3BP1 in response to Wnt3a regulates β-catenin mRNA

Rama Kamesh Bikkavilli et al.

JOURNAL OF CELL SCIENCE (2011)

添加到收藏夹

Article Cell Biology

Crosstalk between Arg 1175 methylation and Tyr 1173 phosphorylation negatively modulates EGFR-mediated ERK activation

Jung-Mao Hsu et al.

NATURE CELL BIOLOGY (2011)

添加到收藏夹

Article Biochemistry & Molecular Biology

Methylation by protein arginine methyltransferase 1 increases stability of Axin, a negative regulator of Wnt signaling

B. Cha et al.

ONCOGENE (2011)

添加到收藏夹

Article Oncology

Clinical evaluation of PRMT1 gene expression in breast cancer

Konstantina Mathioudaki et al.

TUMOR BIOLOGY (2011)

添加到收藏夹

Article Oncology

An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients

Balazs Gyoerffy et al.

BREAST CANCER RESEARCH AND TREATMENT (2010)

添加到收藏夹

Article Oncology

Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells

Berengere Marty et al.

BREAST CANCER RESEARCH (2008)

添加到收藏夹

Article Biochemistry & Molecular Biology

Alternative splicing yields protein arginine methyltransferase 1 isoforms with distinct activity, substrate specificity, and subcellular localization

Isabelle Goulet et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2007)

添加到收藏夹

Article Multidisciplinary Sciences

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

A Subramanian et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.